EUCTR2011-004411-22-PL进行中（未招募）1 期
A multicenter, 52 to 104 week extension study to evaluate the long term growth and development of pediatric hypertensive patients 6 – 17 years of age treated previously with aliskiren
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Successful completion of study CSPP100A2365E1
- •- Patients must meet inclusion criteria set forth for trials CSPP100A2365 and CSPP100A2365E1
- •- Informed consent/ patient assent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Patients who did not successfully complete studies CSPP100A2365 and CSPP100A2365E1
研究者
相似试验
进行中（未招募）
不适用
An extension study to evaluate long term growth and development of hypertensive children 6-17 years of age previously treated with a substance called aliskireMedDRA version: 14.1Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersHypertensionMedDRA version: 14.1Level: PTClassification code 10039834Term: Secondary hypertensionSystem Organ Class: 10047065 - Vascular disordersEUCTR2011-004411-22-Outside-EU/EEAovartis Pharma Services AG200
进行中（未招募）
1 期
An extension study to evaluate long term growth and development of hypertensive children 6-17 years of age previously treated with a substance called aliskireMedDRA version: 17.0 Level: PT Classification code 10020772 Term: Hypertension System Organ Class: 10047065 - Vascular disordersHypertensionMedDRA version: 17.0 Level: PT Classification code 10039834 Term: Secondary hypertension System Organ Class: 10047065 - Vascular disordersEUCTR2011-004411-22-SKovartis Pharma Services AG200
进行中（未招募）
1 期
A long-term extension study to assess the safety and efficacy of GSK3196165 in the treatment of rheumatoid arthritis.Rheumatoid ArthritisEUCTR2019-000878-30-LVGlaxoSmithKline Research & Development Limited3,000
尚未招募
3 期
ong term extension study to assess Efficacy and safety of GSK3196165 in the treatment of rheumatoid arthritisCTRI/2020/12/029972GlaxoSmithKline Research Development Limited
进行中（未招募）
1 期
A long-term extension study to assess the safety and efficacy of GSK3196165 in the treatment of rheumatoid arthritis.MedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2019-000878-30-BEGlaxoSmithKline Research & Development Limited3,000